SG151195A1 - Method for manufacture of escitalopram - Google Patents

Method for manufacture of escitalopram

Info

Publication number
SG151195A1
SG151195A1 SG200806650-8A SG2008066508A SG151195A1 SG 151195 A1 SG151195 A1 SG 151195A1 SG 2008066508 A SG2008066508 A SG 2008066508A SG 151195 A1 SG151195 A1 SG 151195A1
Authority
SG
Singapore
Prior art keywords
escitalopram
manufacture
benzonitrile
hydroxybutyl
hydroxymethyl
Prior art date
Application number
SG200806650-8A
Other languages
English (en)
Inventor
Carla De Faveri
Florian Anton Martin Huber
Robert James Dancer
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39735675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG151195(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SG151195A1 publication Critical patent/SG151195A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C07C253/34—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
SG200806650-8A 2007-09-11 2008-09-10 Method for manufacture of escitalopram SG151195A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200701314 2007-09-11

Publications (1)

Publication Number Publication Date
SG151195A1 true SG151195A1 (en) 2009-04-30

Family

ID=39735675

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200806650-8A SG151195A1 (en) 2007-09-11 2008-09-10 Method for manufacture of escitalopram

Country Status (52)

Country Link
EP (2) EP2061753B1 (lv)
JP (1) JP4966933B2 (lv)
KR (1) KR101054224B1 (lv)
CN (1) CN101386583A (lv)
AR (2) AR068174A1 (lv)
AT (2) ATE518829T1 (lv)
AU (1) AU2008212055C1 (lv)
BE (1) BE1017548A6 (lv)
BG (1) BG110206A (lv)
BR (1) BRPI0804121B1 (lv)
CA (1) CA2638499C (lv)
CH (1) CH697885B1 (lv)
CL (1) CL2008002686A1 (lv)
CO (1) CO6140012A1 (lv)
CY (2) CY2600B1 (lv)
CZ (1) CZ2008537A3 (lv)
DE (1) DE102008046530A1 (lv)
DK (2) DK177075B1 (lv)
EA (1) EA012787B1 (lv)
EE (1) EE00864U1 (lv)
ES (2) ES2334875B1 (lv)
FI (1) FI121570B (lv)
FR (1) FR2920766A1 (lv)
GB (1) GB2448848B (lv)
GR (1) GR1006595B (lv)
HR (2) HRP20080425A2 (lv)
HU (1) HUP0800549A2 (lv)
IE (1) IES20080708A2 (lv)
IL (1) IL193845A (lv)
IS (1) IS8758A (lv)
LT (1) LT5577B (lv)
LU (1) LU91479B1 (lv)
LV (1) LV13813B (lv)
ME (1) ME00176B (lv)
MX (1) MX2008011451A (lv)
MY (1) MY144210A (lv)
NL (1) NL2001953C2 (lv)
NO (1) NO20083756L (lv)
NZ (1) NZ570884A (lv)
PL (2) PL386026A1 (lv)
PT (2) PT104169A (lv)
RO (1) RO125301A2 (lv)
RS (2) RS20080401A (lv)
SE (1) SE533041C2 (lv)
SG (1) SG151195A1 (lv)
SI (2) SI22567A2 (lv)
SK (1) SK500302008A3 (lv)
TR (2) TR200806903A2 (lv)
TW (1) TWI391383B (lv)
UA (2) UA41919U (lv)
WO (1) WO2009033488A1 (lv)
ZA (1) ZA200807753B (lv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1987016A1 (en) 2005-07-27 2008-11-05 Aurobindo Pharma Limited An improved process for the preparation of escitalopram
CN102796065A (zh) * 2011-05-27 2012-11-28 江苏豪森医药集团连云港宏创医药有限公司 一种制备光学纯度高的艾司西酞普兰的方法
CN104119240A (zh) * 2013-04-23 2014-10-29 中国人民解放军军事医学科学院毒物药物研究所 (S)-(-)-α-甲胺基苯丙酮的制备方法
CN103497145B (zh) * 2013-10-10 2016-01-27 南昌大学 一种光学纯多奈哌齐的制备工艺
CN104119248A (zh) * 2014-08-08 2014-10-29 广东东阳光药业有限公司 S-西酞普兰的制备方法
WO2016074225A1 (zh) * 2014-11-14 2016-05-19 浙江华海药业股份有限公司 一种拆分西酞普兰中间体5-氰二醇的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
AR034612A1 (es) 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) * 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
US7390913B2 (en) 2002-12-23 2008-06-24 H. Lundbeck A/S Process for the preparation of racemic citalopram diol and/or S- or R-citalopram diols and the use of such diols for the preparation of racemic citalopram, R-citalopram and/or S-citalopram
WO2004065375A1 (en) * 2003-01-17 2004-08-05 Natco Pharma Limited Processes for the preparation of escitalopram and its precursor
EP1706394B1 (en) * 2003-11-12 2014-12-17 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
EP1877394A1 (en) * 2005-04-04 2008-01-16 Jubilant Organosys Limited Process for the preparation of escitalopram or its acid addition salts
EP1987016A1 (en) * 2005-07-27 2008-11-05 Aurobindo Pharma Limited An improved process for the preparation of escitalopram

Also Published As

Publication number Publication date
BRPI0804121A2 (pt) 2009-09-29
AU2008212055B2 (en) 2010-08-12
FR2920766A1 (fr) 2009-03-13
CL2008002686A1 (es) 2009-01-02
SK500302008A3 (sk) 2009-04-06
LT5577B (lt) 2009-06-25
CA2638499A1 (en) 2008-11-21
AU2008212055C1 (en) 2011-06-02
GR20080100581A (el) 2009-04-30
DE102008046530A1 (de) 2009-03-19
EA200801797A3 (ru) 2009-02-27
EE00864U1 (et) 2009-10-15
EP2061753A1 (en) 2009-05-27
ES2368294T3 (es) 2011-11-16
NO20083756L (no) 2009-03-12
SE0801929L (sv) 2009-03-12
BG110206A (en) 2009-03-31
CA2638499C (en) 2010-09-28
IL193845A (en) 2011-03-31
RO125301A2 (ro) 2010-03-30
SE533041C2 (sv) 2010-06-15
TR200907629A2 (tr) 2009-11-23
PL386026A1 (pl) 2009-02-16
JP4966933B2 (ja) 2012-07-04
EP2397461A1 (en) 2011-12-21
NL2001953C2 (en) 2009-05-07
DK200801265A (en) 2009-03-12
RS51909B (en) 2012-02-29
FI121570B (fi) 2011-01-14
GR1006595B (el) 2009-11-16
TW200906814A (en) 2009-02-16
NZ570884A (en) 2010-03-26
CY1111924T1 (el) 2015-11-04
LT2008068A (en) 2009-03-25
AT10984U1 (de) 2010-02-15
BE1017548A6 (fr) 2008-11-04
EA012787B1 (ru) 2009-12-30
NL2001953A1 (nl) 2008-12-22
ATE518829T1 (de) 2011-08-15
EP2061753B1 (en) 2011-08-03
KR101054224B1 (ko) 2011-08-08
PT104169A (pt) 2009-02-02
HU0800549D0 (en) 2008-10-28
SI22567A2 (sl) 2008-12-31
EA200801797A2 (ru) 2008-12-30
TWI391383B (zh) 2013-04-01
UA43461U (uk) 2009-08-25
KR20090027185A (ko) 2009-03-16
WO2009033488A1 (en) 2009-03-19
HRP20080425A2 (hr) 2010-04-30
CY2600B1 (en) 2010-03-03
ES2334875B1 (es) 2010-10-27
DK2061753T3 (da) 2011-09-26
MX2008011451A (es) 2009-03-10
BRPI0804121B1 (pt) 2022-04-12
RS20080401A (en) 2010-03-02
FI20085807A0 (fi) 2008-08-29
CZ2008537A3 (cs) 2009-03-18
HRP20110636T1 (hr) 2011-10-31
IS8758A (is) 2009-03-12
IES20080708A2 (en) 2009-03-18
CH697885B1 (de) 2009-03-13
MY144210A (en) 2011-08-15
LU91479B1 (fr) 2010-03-11
UA41919U (uk) 2009-06-10
FI20085807A (fi) 2009-03-12
GB2448848A (en) 2008-10-29
GB2448848B (en) 2011-01-26
PT2061753E (pt) 2011-09-14
DK177075B1 (da) 2011-06-14
SI2061753T1 (sl) 2011-10-28
HUP0800549A2 (en) 2009-03-02
CO6140012A1 (es) 2010-03-19
ES2334875A1 (es) 2010-03-16
AR068174A1 (es) 2009-11-11
MEP10108A (en) 2010-10-10
TR200806903A2 (tr) 2009-03-23
ME00176B (me) 2011-02-10
JP2009149600A (ja) 2009-07-09
PL2061753T3 (pl) 2011-12-30
BRPI0804121A8 (pt) 2021-04-13
GB0815773D0 (en) 2008-10-08
CN101386583A (zh) 2009-03-18
LV13813B (en) 2008-11-20
AU2008212055A1 (en) 2009-03-26
ZA200807753B (en) 2009-04-29
AR108885A2 (es) 2018-10-03

Similar Documents

Publication Publication Date Title
AR108885A2 (es) Método para la elaboración de escitalopram
UY35850A (es) Proceso para la preparación del citalopram racemico y/o del s-ó r-citalopram mediante la separación de una mezcla de r-y s-citalopram
ATE455752T1 (de) Herstellung von (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpent namin
NO341683B1 (no) Fremgangsmåte for fremstilling av 3-[(1R,2R)-3-(dimetylamino)-1-etyl-2-metylpropyl]fenol samt forbindelse
JP2009530282A5 (lv)
ATE449096T1 (de) Verfahren zur herstellung von 3(r)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-p enoxypropyl)-1- azoniabicycloä2.2.2üoctanbromid
ATE327972T1 (de) Verfahren zur herstellung von optisch-reinen (r)- und (s)- didesmethylsibutramin
ATE513840T1 (de) Verfahren zur herstellung optisch aktiver diphosphane
HK1099759A1 (en) A process for the resolution of nefopam
ES2285972T1 (es) Procedimiento de fabricacion de citalopram y enantiomeros.
DK1733042T3 (da) Kemo-enzymatisk fremgangsmåde til fremstilling af escitalopram
WO2008029257A3 (en) Improved method for preparing 1,3-disubstituted pyrrolidine compounds
WO2006127331A3 (en) Conversion process for 2,3-benzodiazepine enantiomers
ATE534639T1 (de) Verfahren zur lösung von citalopram
ATE387423T1 (de) Verfahren zur herstellung der enantiomeren formen von 2,3-diaminopropionsäurederivaten
ATE415388T1 (de) Verfahren zur herstellung von enantiomerenreinen 4-pyrrolidinophenyl- benzyletherderivaten
ATE550422T1 (de) Verfahren zur herstellung von mycophenolsäure mit penicillium arenicola bicc7673